Comparative Study
doi: 10.1128/AAC.32.4.601.
In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria
Affiliations
- PMID: 3163908
- PMCID: PMC172231
- DOI: 10.1128/AAC.32.4.601
Item in Clipboard
Comparative Study
In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria
Antimicrob Agents Chemother.
1988 Apr.
Abstract
The activity of cefotetan against 430 strains of anaerobic bacteria was compared with that of cefoxitin, ceftizoxime, clindamycin, metronidazole, and chloramphenicol. Percent susceptible values for the Bacteroides fragilis group were 60, 80, 29, 86, 100, and 100%, respectively. Percent susceptible values for the B. fragilis species were 91, 92, 46, 98, 100, and 100%, respectively. Non-B. fragilis-group Bacteroides species were inhibited very well (90 to 100%) by all drugs except ceftizoxime (80%). Cefotetan and metronidazole were the most active agents against Clostridium difficile. Percent susceptible values for all strains were 72, 79, 44, 82, 93, and 98%, respectively.
Similar articles
-
A multicenter study of the in vitro antianaerobic activity of cefotetan compared with other antimicrobial agents.Am J Surg. 1988 May 31;155(5A):47-51. doi: 10.1016/s0002-9610(88)80212-5. Am J Surg. 1988. PMID: 3163901
-
Comparative in vitro beta-lactam activity against aerobic and anaerobic surgical isolates.Diagn Microbiol Infect Dis. 1988 Feb;9(2):105-13. doi: 10.1016/0732-8893(88)90103-4. Diagn Microbiol Infect Dis. 1988. PMID: 3164263
-
The comparative in-vitro activity of cefotetan against anaerobic bacteria.J Antimicrob Chemother. 1985 Jun;15(6):671-7. doi: 10.1093/jac/15.6.671. J Antimicrob Chemother. 1985. PMID: 3861604
-
An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.Clin Ther. 1990;12 Suppl C:3-12. Clin Ther. 1990. PMID: 2202509 Review.
-
Cefotetan: a review of the microbiologic properties and antimicrobial spectrum.Am J Surg. 1988 May 31;155(5A):16-23. doi: 10.1016/s0002-9610(88)80207-1. Am J Surg. 1988. PMID: 3287964 Review.
Cited by
-
Susceptibility testing of anaerobic bacteria: myth, magic, or method?Clin Microbiol Rev. 1991 Oct;4(4):470-84. doi: 10.1128/CMR.4.4.470. Clin Microbiol Rev. 1991. PMID: 1747863 Free PMC article. Review.
-
Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents.Antimicrob Agents Chemother. 1992 Sep;36(9):2051-3. doi: 10.1128/AAC.36.9.2051. Antimicrob Agents Chemother. 1992. PMID: 1416899 Free PMC article.
-
New developments and concepts in antimicrobial therapy for intra-abdominal infections.Curr Gastroenterol Rep. 2000 Aug;2(4):277-82. doi: 10.1007/s11894-000-0019-7. Curr Gastroenterol Rep. 2000. PMID: 10981024 Review.
-
Metronidazole. A therapeutic review and update.Drugs. 1997 Nov;54(5):679-708. doi: 10.2165/00003495-199754050-00003. Drugs. 1997. PMID: 9360057 Review.
-
Cefotetan: a second-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.CMAJ. 1994 Sep 1;151(5):537-42. CMAJ. 1994. PMID: 8069799 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
